CAR T CELLS THERAPY

A Breakthrough in Leukemia Treatment: CAR-T Therapy

CAR-T therapy, or Chimeric Antigen Receptor T-Cell Immunotherapy, is a revolutionary form of gene therapy that harnesses the body's immune system to combat cancer. This personalized treatment involves modifying a patient's T cells to specifically target and eliminate cancer cells. Unlike traditional therapies, CAR-T therapy is tailored to each individual, offering a promising approach for various types of leukemia and lymphoma.

CAR-T Therapy Applications

CAR-T therapy has demonstrated remarkable effectiveness in treating:

•    B-cell acute lymphoblastic leukemia
•    Multiple myeloma
•    Chronic lymphocytic leukemia
•    Non-Hodgkin lymphoma
•    Diffuse large B-cell lymphoma
•    Systemic Lupus Erythematosus (SLE)
•    Myasthenia gravis
•    Other autoimmune diseases

Exceptional CAR-T Clinical Outcomes

Our CAR-T therapies have shown exceptional results in clinical trials:
​​​​​​​
•    CD19+20 CAR-T: High rates of complete and overall response in patients with B-cell non-Hodgkin's lymphoma.
•    CD19+22 CAR-T: Demonstrated significant efficacy in treating relapsed and refractory acute B-lymphocytic leukemia.
•    BCMA CAR-T: Proven effective in managing relapsed and refractory multiple myeloma.


Our Commitment to Excellence

At CHINAMEDTOURS, we are dedicated to providing cutting-edge CAR-T therapy solutions. Our approach is characterized by:

•    Personalized Treatment: Tailored therapies to address each patient's unique needs.
•    Diverse Targeting Options: A range of CAR-T products targeting different cancer cells.
•    Advanced Technology: Utilizing the latest advancements in gene engineering and immunotherapy.
•    Cost-Effective Solutions: Balancing quality assurance with competitive pricing.
•    Expert Care: A team of experienced clinicians and researchers dedicated to patient well-being.
•    Comprehensive Support: From initial evaluation to post-treatment care.
CAR-T therapy offers hope for patients with treatment-resistant leukemias and lymphomas. We are committed to advancing this transformative therapy and improving the lives of our patients.


CONTACT US